British Columbia Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,714
Closed -$398K 828
2022
Q3
$398K Sell
15,714
-2,882
-15% -$101K ﹤0.01% 781
2022
Q2
$618K Sell
18,596
-3,646
-16% -$155K 0.01% 764
2022
Q1
$1.6M Sell
22,242
-2,909
-12% -$210K 0.01% 700
2021
Q4
$2.31M Sell
25,151
-489
-2% -$58.4K 0.01% 664
2021
Q3
$3.25M Buy
25,640
+530
+2% +$77.2K 0.02% 565
2021
Q2
$4.18M Buy
25,110
+6,158
+32% +$998K 0.03% 486
2021
Q1
$3.44M Sell
18,952
-359
-2% -$83.3K 0.02% 481
2020
Q4
$3.86M Buy
19,311
+7,045
+57% +$1.43M 0.03% 447
2020
Q3
$2.69M Buy
12,266
+988
+9% +$209K 0.02% 501
2020
Q2
$2.15M Buy
+11,278
New +$1.98M 0.02% 517

Other funds holding TDOC

British Columbia Investment Management's TDOC Position: Q4 2022 in Review

British Columbia Investment Management sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 15,714 shares — an estimated $398K sold.

British Columbia Investment Management first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $4.18M in Q2 2021. 445 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • British Columbia Investment Management reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • British Columbia Investment Management sold 15,714 Teladoc Health shares in Q4 2022, an estimated $398K.
  • British Columbia Investment Management first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • British Columbia Investment Management's Teladoc Health position peaked at $4.18M in Q2 2021.
  • 445 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on British Columbia Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.